183 related articles for article (PubMed ID: 16520902)
1. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement.
Wang Y; Yuan F
Ann Biomed Eng; 2006 Jan; 34(1):114-27. PubMed ID: 16520902
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene-delivery strategies for angiostatic cancer treatment.
Brandwijk RJ; Griffioen AW; Thijssen VL
Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
[TBL] [Abstract][Full Text] [Related]
3. Strategies to enhance viral penetration of solid tumors.
Smith E; Breznik J; Lichty BD
Hum Gene Ther; 2011 Sep; 22(9):1053-60. PubMed ID: 21443415
[TBL] [Abstract][Full Text] [Related]
4. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.
Cole C; Qiao J; Kottke T; Diaz RM; Ahmed A; Sanchez-Perez L; Brunn G; Thompson J; Chester J; Vile RG
Nat Med; 2005 Oct; 11(10):1073-81. PubMed ID: 16170322
[TBL] [Abstract][Full Text] [Related]
6. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
7. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
[TBL] [Abstract][Full Text] [Related]
8. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
10. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.
García-Castro J; Martínez-Palacio J; Lillo R; García-Sánchez F; Alemany R; Madero L; Bueren JA; Ramírez M
Cancer Gene Ther; 2005 Apr; 12(4):341-9. PubMed ID: 15650763
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics.
Liu TC; Wakimoto H; Martuza RL; Rabkin SD
Clin Cancer Res; 2007 Oct; 13(19):5897-902. PubMed ID: 17908985
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus vectors: use and optimisation in cancer gene therapy.
Blechacz B; Russell SJ
Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
Li SD; Huang L
Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
[TBL] [Abstract][Full Text] [Related]
14. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
16. A novel method for viral gene delivery in solid tumors.
Wang Y; Liu S; Li CY; Yuan F
Cancer Res; 2005 Sep; 65(17):7541-5. PubMed ID: 16140915
[TBL] [Abstract][Full Text] [Related]
17. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies.
Wang T; Upponi JR; Torchilin VP
Int J Pharm; 2012 May; 427(1):3-20. PubMed ID: 21798324
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.
Yun CO
Curr Opin Mol Ther; 2008 Aug; 10(4):356-61. PubMed ID: 18683100
[TBL] [Abstract][Full Text] [Related]
19. Nuclear targeting of viral and non-viral DNA.
Chowdhury EH
Expert Opin Drug Deliv; 2009 Jul; 6(7):697-703. PubMed ID: 19552613
[TBL] [Abstract][Full Text] [Related]
20. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
